0 items USD 0.00Search
Your search for "mrrpb5 global lamea oncologyanti cancer drugs market research report 2018" gave back 1597207 results.
Bladder cancer is a disease in which malignant (cancer) cells form in the tissues of the bladder. Targeted therapy is a treatment that targets the...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
PARP inhibitors are a group of pharmacological inhibitors of the enzyme poly ADP ribose polymerase (PARP) The global Cancer Drug based on PARP...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Indoleamine 2,3 Dioxygenase 1 (Indoleamine Pyrrole 2,3 Dioxygenase 1 or IDO1 or EC 1.13.11.52) - Pipeline Review, H2 2018 Summary Indoleamine 2,3...
Catalog:
Global Markets Direct
October 2018
Price: USD 3,500.00
There are few available adjuvant/neoadjuvant medicines for treatment of high-risk resectable colorectal cancer. Lack of pipeline agents in this...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Highlights The global Ureter Cancer Drugs market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
The global Gynecological Cancers Drug market size is expected to reach US$ 37710 million by 2029, growing at a CAGR of 4.2% from 2023 to 2029. The...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
Baculoviral IAP Repeat Containing Protein 5 (Apoptosis Inhibitor 4 or Apoptosis Inhibitor Survivin or BIRC5) - Pipeline Review, H1 2018 Summary...
Catalog:
Global Markets Direct
January 2018
Price: USD 3,500.00
Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1) - Pipeline Review, H1 2018 Summary According to the recently published report...
Catalog:
Global Markets Direct
May 2018
Price: USD 3,500.00
Cancer vaccines offer an attractive therapeutic addition, delivering treatment of high specificity, low toxicity and prolonged activity. Highlights...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
Global Urological Cancer Therapeutics Drugs Market is estimated to reach $48.6 billion by 2025 Says, .Now a days urological cancers became very...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Highlights The global Testicular Cancer Drugs market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
Urothelial carcinoma or transitional cell carcinoma is a malignant neoplasm occurring from urothelium. The disease is the ninth most common...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Vaginal Cancer - Pipeline Review, H1 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Vaginal...
Catalog:
Global Markets Direct
May 2018
Price: USD 2,000.00
Cervical cancer is an uncontrolled growth of cells in the cervix region, which is accompanied by symptoms such as abnormal vaginal bleeding, pelvic...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
Bladder cancer drugs are used to treat bladder cancer, prevent, inhibit, and eliminate bladder cancer cells from various aspects, so that the patient...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
